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Abstract
Cancers are caused by the accumulation of genetic alterations. Since this accumu-
lation takes time, the incidence of most cancers is thought to increase exponentially
with age. However, careful measurements of the age-specific incidence shows that the
specific incidence for many forms of cancer rises with age to a maximum, then decreases.
This decrease in the age-specific incidence with age is an anomaly. Understanding this
anomaly should lead to a better understanding of how tumors develop and grow. Here
I derive the shape of the age-specific incidence, showing that it should follow the shape
of a Weibull distribution. Measurements indicate that the age-specific incidence for
colon cancer does indeed follow a Weibull distribution. This analysis leads to the in-
terpretation that for colon cancer two sub-populations exist in the general population:
a susceptible population and an immune population. Colon tumors will only occur in
the susceptible population. This analysis is consistent with the developmental origins
of disease hypothesis and generalizable to many other common forms of cancer.
Introduction
Cancers are thought to originate after a series of genetic alterations accumulate in a cell. These
alterations could consist of mutations, deletions or modifications to the DNA. The accumulation of
alterations increases when certain pathological states occur: chromosomal instability, DNA repair
defects. A typical colorectal cancer genome contains about a dozen mutated genes that are consid-
ered to be driving the cancer [1,2]. Since a normal cell needs to accumulate mutations to more than
a dozen key genes before transforming into a tumor cell [3], the probability of acquiring a particular
cancer should increase with age. Thus, it is widely thought that the older one gets, the more likely
one is to develop cancer. Age is the primary risk factor for cancer, and cancer is considered an age
related disease [4]. The textbook understanding of how age relates to cancer is shown in Figure 1.
However, the incidence of most cancers does not monotonically increase with age; instead, the
incidence increases to a maximum at some age and then decreases. Although this anomaly is well
established [6–8], it is not widely known.
A complete understanding of the age-specific incidence should lead to a better understanding
of how cancers develop. The age-specific incidence is the only quantitative data available on the
development process of cancer. It is not confounded by animal models. One of the primary steps
to understanding the age-specific incidence is to understand the anomaly.
Thought experiments
We can begin with a gedanken experiment. Take 100,000 newborn human infants and put them in
an isolated box. These babies live well, and grow into adults. In this idealized experiment, they do
not die of any ailments. Each of these experimental subjects is regularly examined for a particular
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Figure 1: The textbook illustration of how cancer incidence increases with age. The specific inci-
dence of cancers is often depicted as exponentially increasing with age. An illustration similar to
this appears in a popular undergraduate molecular biology textbook [5].
type of cancer, say colon cancer. When a subject is first diagnosed with a colon cancer, the exact
age is recorded. The experiment runs for hundreds of years, then we make a histogram of the
number of colon cancers diagnosed as a function of years since the beginning of the experiment.
This histogram will start near zero, reach a maximum, then decline to zero again when all
subjects have been diagnosed with a first case of colon cancer, as shown in Figure 2. If every
member of the initial population of infants ultimately developed the cancer, then the integral of
this histogram should be equal to the population, in this case, 100,000.
A second gedanken experiment is also performed. In this case, the population of 100,000 infants
is composed of two apparently indistinguishable sub populations, one of which can develop colon
cancer (20%), and the other of which cannot(80%). The same process is followed. At the end of
the experiment, the integral of the histogram is calculated and it will equal 20,000.
While these gedanken experiments are unrealistic, an analogous experiment can be done. First,
we record the age of all patients diagnosed with a specific cancer within a large geographic area
in one year. Second, we record the age of each member in the entire population. Finally, for each
age group, we divide the number of patients who had a tumor diagnosed in that year by the total
number of people with that age in the population. By convention, these numbers are multiplied by
100,000 and are called the age-specific incidence.
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Figure 2: The postulated results of a simple thought experiment. The experiment consists of
100,000 newborn humans isolated and monitored annually for colon cancer. The number diagnosed
with colon cancer for the first time is recorded each year. After several hundred years, the data is
plotted. The plot shows that the incidence increases, reaches a maximum, then decreases to zero.
The decrease occurs when the majority of the population has already been diagnosed once with
colon cancer.
Population based cancer registries
Population based cancer registries record the age (and other information) about all patients diag-
nosed with all types of tumors within a specific geographic area. Then, a government census records
the ages of all members of the population within a specific geographic area. Together these sources
of data can be combined to compute the age-specific incidence data.
The collection and quality of age-specific incidence data has significantly improved since reg-
istries began in the mid 1900’s. Initially, this data was derived from death certificates. However,
many deaths were attributed to “old age” or nonstandard terminology. Today, cancer registries
systematically collect information on the diagnosis of tumors and demographic information of the
patient.
Different cancer registries, however, collect different information. These differences make ag-
gregation of cancer registry data difficult. In 1973, the National Cancer Institute established the
Surveillance, Epidemiology, and End Results (SEER) program. The SEER network of cancer reg-
istries solved many of these problems by requiring a specific set of information to be reported and
established guidelines on how to encode different properties of a tumor.
The SEER network of cancer registries began in 1973 with seven different geographic registries
covering 16 million people. The program has expanded from seven cancer registries in 1973 to
18 cancer registries in 2012, with about 86 million people under surveillance. The SEER program
publishes annually case files, which contain summary information about all tumors diagnosed within
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the specific geographic areas.
Age-specific incidence data collected by the SEER-17 network of cancer registries in 2000 is
shown in Figure 3. This data is presented to emphasize that different cancers have different max-
imum ages. In each of the seven cancers shown, a decrease in incidence with age exists. This
decrease is anomalous, the opposite of the expected behavior, but is consistent with our gedanken
experiments.
Anomaly or Artifact?
A number of concerns have been raised with the surprising observation that the age-specific incidence
decreases with age. The three most common are (1) this observation is contradicted by autopsy
studies of latent carcinoma, (2) this observation is an artifact caused by decreased screening rates
with age, and (3) this observation is the result of a birth cohort effect. Each of these concerns has
been studied in great detail and none of these are sufficient to explain the anomaly.
Autopsy studies of latent carcinoma. A widespread perception exists that undiagnosed
carcinomas, or latent carcinomas, are common in elderly people. Much of this perception is due to
work done in the 1950’s by LM Franks, who performed several autopsy studies [9, 10]. His work
appeared to show that many undiagnosed cancers existed in people who died. This work was based
on rather small numbers (for instance, [10] only had two subjects in the 90-100 year old age group.)
This data has not been replicated, moreover recent autopsy studies on larger populations [11, 12]
contradict Frank’s results and have established that the incidence of many common carcinomas
decreases after a certain age.
Screening and age-specific incidence data. The effect of cancer screening on colorectal
cancer rates can be estimated. Colorectal screening rates decrease with age after 60 years. The
National Survey of Ambulatory Surgery quantified the rate of outpatient colonoscopies (over 90%
of colonoscopies are performed as outpatients) in 1994, 1995, 1996 and 2006 [13]. (The survey was
not performed in the years between 1996 and 2006.) Based on these estimates, colorectal screening
rates in the elderly population (over 85) were about 40% of the rate of 50 to 64 year olds.
The increase in diagnosed cancers due to screening can be estimated from the age-specific in-
cidence data. Guidelines suggest beginning screening at 50 years of age. The colon carcinoma
age-specific incidence data shows a small, but noticeable, increase over the expected rate at 50
years of age. From this, we estimate the number of new cases of colon carcinoma due to screening
at about 2 per 100,000, when about 5000 per 100,000 are screened. Based on these numbers, we
estimate that if screening rates did not decrease with age, the specific incidence of colon carci-
noma would increase by about 40 cases per 100,000 population at age 85. This is not a significant
difference.
Birth cohort effects on age-specific incidence data. The drop in the incidence of colon
cancer after age 85 is not due to birth cohort effects. The expected value, if 100% of the population
were susceptible, for age 99 is about 850 per 100,000, as shown in data from 200 shown Figure 4. The
observed value is about 227 with a 95% confidence interval of 96 to 357. The observed value is about
one quarter of the expected value of colon carcinoma incidence, if 100% were susceptible to colorectal
carcinoma. If this population, born in 1900-1910, had a significantly reduced propensity to develop
colorectal carcinoma, then we should see a correspondingly small incidence in the population aged
72 years old recorded in 1973 (the earliest SEER data available). No such effect is noticeable in the
1973 data.
Finally, one other objection to the observation of declining cancer incidence with age is sometimes
raised mistakenly: competing risk. Competing risk is not relevant here. It is relevant to studies with
fixed populations when some members of the population die from other causes. The age-specific
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incidence data is not based on fixed populations. Specific incidence is the number of diagnosed
cancers divided by the population.
Understanding the age-specific incidence data
We follow two approaches to understand the age-specific incidence data. The first approach is
theoretical: based on first principles, what should be the shape of the age-specific incidence curve?
The second approach asks what biomedical hypothesis could produce age-specific incidence data
that we observe.
A theory of the age-specific incidence curve. We have postulated that the age-specific
incidence curve should follow a extreme value distribution, in particular the Weibull distribution [14].
Our reasoning is that:
1. Tumors originate in a single cell, the progenitor cell.
2. Many potential progenitor tumors cells exist in the body for each type of potential tumor.
3. A tumor develops when the first of these many potential progenitor cells.
These steps describe an extreme value process. The Weibull distribution is the proper distribution
to characterize this process [15].
The probability of developing a particular cancer as a function of time, p(t), is given by the
Weibull distribution
p(t) = A
(
k
λ
)(
t− τ
λ
)k−1
exp−(
t−τ
λ
)k , (1)
when t ≥ τ and the Weibull distribution is p(t) = 0 when t < τ . The Weibull distribution has four
parameters: A is a normalization factor, τ is the time shift, k is called the shape parameter, and λ
is the scale parameter. Both k and λ must be positive.
We compared the theoretical shape of the age-specific incidence data with observational data
collected by the SEER-17 registries in 2000 for colon cancer. We computed the best fit theoretical
shape to the 0-84 year old data in two cases. First, when all three parameters (A, k, λ) were allowed
to vary and second when A was fixed to be 100,000, but the other two parameters were allowed to
vary. These results are shown in Figure 4.
The two fits in Figure 4 correspond to the two gedanken experiments. If everyone eventually
will develop colon cancer, the data points should fall on the 100% line. We observe the 86-100 years
old data points, which were not involved in the fitting, to fall on the 11.8% curve.
This analysis suggests that two subpopulations exist. One subpopulation, consisting of about
12% of the population, is susceptible to developing colon cancer. The second subpopulation, con-
sisting of about 78% of the population is immune to developing colon cancer. Membership in the
susceptible population must be determined early, before the age of 20.
One objection to this interpretation is that it apparently contradicts the well-established obser-
vation that modifiable risk factors exist for most common cancers. The link between environmental
exposure and increased cancer rates is well established, most prominently between cigarette smok-
ing and lung cancer. If environmental exposure causes cancer, how can a susceptible subpopulation
exist and be defined at an early age?
One possible explanation is that environmental risk factors effect how fast a tumor grows. For
instance, a non-smoker predisposed to lung cancer might develop a lung tumor at age 120, while a
similar heavy smoker develops a tumor at age 60. Since the non-smoker will probably die from other
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causes before the lung tumor develops, it appears that the smoker developed lung cancer while the
non-smoker did not develop lung cancer.
The idea that disease observed late in life could originate early in life is not novel. This idea is
called the developmental origin of disease hypothesis [16–18]
Developmental origin of disease hypothesis. Different forms of this hypothesis have been
proposed [19,20]. Trichopoulos has suggested that hormonally regulated cancers originate in utero.
He points out that this would explain a number of curious observations about breast cancer including
the dramatic difference in incidence found in Japan and the USA [21]. Barker has suggested that
not only cancers, but also other adult diseases have fetal origins [16,22]. Others have also suggested
that some chronic diseases are influenced by exposure to environmental factors early in life [23,24].
Diabetes [25], schizophrenia [26], and lung disease [27] might also find their origins in early life.
Mechanisms for the developmental origins of disease hypothesis. Several known mech-
anisms could be responsible for the existence of two sub populations, these include germ line mu-
tations, somatic mutations early in life, and/or epigenetic modifications inherited or acquired early
in life.
Germ line mutations have been ruled out. During the 1990’s, significant resources were devoted
to the identification of germ line mutations for the most common forms of cancers. This effort led
to the identification of BRCA1 [28]. Certain mutations in BRCA1 significantly increase the risk
that a woman will develop breast cancer. However, these mutations are rare and less than 10%
of breast cancers in the US population occur in women with these mutations. Despite searching
for similar genes in colon cancer [29], none have been found with the significance of BRCA1. No
recurrent mutations are responsible for the progression of colon cancer [30].
Somatic mutations acquired early in life (during development) could propagate to encompass
entire tissues. Embryonic cells are actively proliferating and a somatic mutation acquired early
during development will be found in many cells. Irradiation of a fetus is known to increase the
incidence of childhood cancers [31] presumably through the acquisition of somatic mutations. So-
matic mutations acquired during development are known to be responsible for retinoblastoma, a
childhood cancer [32].
Epigenetic alterations play a key role in the carcinogenesis process [33–35]. These types of
alterations can be passed down through cellular generations. Modification of histones are a key
regulatory step in transcription [36] and DNA damage repair [37]. Specific histone modifications
have been identified that are common features of human cancers [38, 39]. Several approaches to
determining genome wide methylation exist, but these approaches have not yet been widely applied
to cancer [40].
Conclusion
In conclusion, we showed that logically (through gedanken experiments), theoretically, and observa-
tionally that the age-specific incidence data decreases with age. This apparent anomaly is consistent
with the developmental origin of disease hypothesis.
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Figure 3: Many different forms of cancer exhibit the age-specific incidence anomaly. This figure
shows that cancers of the bone, testicles, prostate, breast, colon, and lung all increase with age, reach
a maximum, then decrease. Understanding this anomalous decrease in the age-specific incidence
should lead to a better understanding of how cancers begin.
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Figure 4: The age-specific incidence of colon carcinoma, as measured by the SEER-17 network of
cancer registries in 2000, is plotted along with the best fit Weibull distribution for 100% of the
population and for 11.8% of the population. Both distributions were fit to data from ages 0 to 85
years of age, then data from 86-99 years of age were plotted. The data is clearly consistent with
the 11.8% curve, but not the 100% curve.
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